Ono Pharmaceutical: [Postponed] Corporate Governance Report
Ono Pharmaceutical: Announcements of individual stocks regarding the results of the public tender offer for shares of Deciphera Pharmaceuticals, Inc. in the USA and acquisition completion (total subsidiaryization).
Ono Pharmaceutical: Independent Officer Notification Form
Ono Pharmaceutical: Notice regarding the conclusion of an agreement to acquire Deciphera Pharmaceuticals in the United States
Ono Pharmaceutical: Notice regarding personnel affairs of directors, auditors, and executive officers
Ono Pharmaceutical: Corporate Governance Report
Ono Pharmaceutical: Corporate Governance Report
Ono Pharmaceutical: Corporate Governance Report
Ono Pharmaceutical: Notice regarding a comprehensive settlement with AstraZeneca regarding anti-PD-1 antibody/anti-CTLA-4 antibody-related patent lawsuits
Ono Pharmaceutical: [Delayed]Corporate Governance Report
Ono Pharmaceutical: Notice regarding the acquisition of shares of Michiteku, a subsidiary of Ono Pharmaceutical, and Nekojudo, a Kansai Electric Power Group company
Ono Pharmaceutical: Ono Pharmaceutical establishes OphRs Co., Ltd.
Ono Pharmaceutical: Independent Officer Notification Form
Ono Pharmaceutical: Notice regarding full settlement of lawsuits relating to anti-PD-1 PD-L1 antibody related patents
Ono Pharmaceutical: Notice regarding personnel affairs of directors, auditors, and executive officers
Ono Pharmaceutical: Articles of association 2023-03-02
Ono Pharmaceutical: Establish a general consortium, "Ono Pharmaceutical Cancer, Immunology, and Neurological Research Group"
Ono Pharmaceutical: Signed an exclusive option asset acquisition agreement with Equillium for the development and commercialization of anti-CD6 antibody "itolizumab"
Ono Pharmaceutical: Ono Pharmaceuticals, established michiteku Co., Ltd. as a new business subsidiary
Ono Pharmaceutical Co Ltd: Corporate Governance Report
No Data